Interestingly, a study using an in vivo myeloid cell-specific deletion of VEGF and tested its impact on vessel density and tumor progression in various murine tumor models in order to determine the role of myeloid cell-derived VEGF in this context (49). The gene discussed is VEGFA; the disease is neoplasm.